
Styrax Laboratories Private Limited
About Styrax Laboratories Private Limited
Data last updated:
Styrax Laboratories Private Limited is a private limited company based in Kurmannapalem, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24100AP2016PTC121863. Its GSTIN is 37AAXCS1089D1ZV (Andhra Pradesh).
The company has an authorised share capital of ₹9.9 Cr and a paid-up capital of ₹9.76 Cr. It is led by directors including Sreenath Suryadevara and Lakshmi Devi Suryadevara.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No. 407 4th Floor Block – D Palace Heights Shivaji Nagar, Kurmannapalem, Andhra Pradesh, India – 530046.
As per the financials filed for FY 2023, the company reported a revenue of ₹53.44 Lakh, a decline of 88% compared to the previous year. For the same year it recorded a net profit of ₹35.46 Lakh (net margin 66.4%) and EBITDA of -₹3.55 Lakh (EBITDA margin -6.6%).
The company has 1 deal on record (1 funding round), with disclosed funding of ₹9.75 Cr; the latest was in July 2016.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Styrax Laboratories has one previous CIN (Corporate Identification Number): U24100TG2016PTC103927. The current CIN is U24100AP2016PTC121863, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100AP2016PTC121863 | Current |
| U24100TG2016PTC103927 | Previous |
Contact details
Styrax Laboratories Private Limited's registered office is in Kurmannapalem, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 407 4th Floor Block – D Palace Heights Shivaji Nagar, Kurmannapalem, Andhra Pradesh, India – 530046
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Styrax Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Styrax Laboratories Private Limited
FY 2024 filings availableStyrax Laboratories Private Limited reported revenue of ₹53.44 Lakh (down 88% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 88% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹53.44 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.6% | ||||
| Net Profit Margin | 66.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Styrax Laboratories Private Limited, buy the company report.
Board of directors of Styrax Laboratories Private Limited
Styrax Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreenath Suryadevara Also directs: Auctus Life Sciences LLP, Styrax Pharma Private Limited | Director | 16 Mar 2016 | 10 Years 7 Months | Current |
| Lakshmi Devi Suryadevara | Director | 16 Mar 2016 | 10 Years 7 Months | Current |
| Suryadevara Venkateswara Rao | Director | 16 Mar 2016 | 10 Years 7 Months | Current |
Auditor
Styrax Laboratories Private Limited is audited by L N P & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| L N P & Co | FY 2023 | 008918S |
Shareholding
The shareholding of Styrax Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Styrax Laboratories Private Limited, buy the company report.
Deals & funding
Styrax Laboratories Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹9.75 Cr; the latest was in July 2016.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2016 | Funding round | ₹9.75 Cr | Investors: Suryadevara Venkateswara Rao HUF, an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Styrax Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Styrax Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Styrax Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAXCS1089D1ZV | Andhra Pradesh | Active | 22 Feb 2018 |
To see the full GST registrations and return filing status of Styrax Laboratories Private Limited, buy the company report.
Recent activity
Styrax Laboratories Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Lakshmi Devi Suryadevara was appointed as Director on 16 Mar 2016.
Frequently asked questions
Styrax Laboratories is an active private limited company based in Kurmannapalem, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2016 (10+ years old) and is registered under CIN U24100AP2016PTC121863.
Styrax Laboratories has 3 current directors:
- Sreenath Suryadevara - Director
- Lakshmi Devi Suryadevara - Director
- Suryadevara Venkateswara Rao - Director
The latest financial statements of Styrax Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Styrax Laboratories is 37AAXCS1089D1ZV, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Styrax Laboratories is U24100AP2016PTC121863. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Styrax Laboratories was incorporated on 16 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Vijayawada.
Styrax Laboratories has 1 deal on record (1 funding round), with disclosed funding of ₹9.75 Cr; the latest was in July 2016.
Lakshmi Devi Suryadevara was appointed as Director on 16 Mar 2016. Sreenath Suryadevara was appointed as Director on 16 Mar 2016. Suryadevara Venkateswara Rao was appointed as Director on 16 Mar 2016.
The registered office of Styrax Laboratories is at Flat No. 407 4th Floor Block – D Palace Heights Shivaji Nagar, Kurmannapalem, Andhra Pradesh, India – 530046.
Styrax Laboratories operates in the pharma industry, in the drug formulation and development segment.